HANSEN-TECHNOLOGIES
29.1.2020 00:02:06 CET | Business Wire | Press release
Hansen Technologies is pleased to announce that it has signed a new agreement with longstanding customer Simply Energy, to augment the energy retailer’s existing Hansen HubCX platform with Sigma Catalog and Sigma CPQ.
The Australian retail arm of the global ENGIE group, Simply Energy has more than 720,000 customer accounts in Victoria, South Australia, New South Wales, the Australian Capital Territory, Western Australia and Queensland.
Under the terms of this agreement, Hansen Technologies will deploy Sigma Catalog and Sigma CPQ , which constitute part of Sigma Systems’ Create-Sell-Deliver Portfolio . The deal marks a significant progression for Hansen since acquiring Sigma last year and represents a strategic insertion of Sigma’s portfolio into the energy market, while facilitating a more digitalized business approach for Simply Energy.
Shannon Hyde, Chief Executive Officer, Simply Energy, commented: “In recent years, we have seen changes in the economic and regulatory landscape in Australia, requiring us to reorient the way we choose to cater to our valued customers across the country. In order to deliver the best experiences for our customers, we are pleased to deepen our relationship with Hansen Technologies. Hansen’s HubCX platform, coupled with Sigma Catalog and Sigma CPQ, now gives Simply Energy a holistic solution that allows us to further digitally enable our business and traverse new complexities in the energy market.”
Andrew Hansen, Group Chief Executive Officer, Hansen Technologies, commented : “This new agreement with one of the country’s leading energy retailers is an affirmation of Simply Energy’s trust in Hansen Technologies’ product portfolio and expertise, as the company looks to thrive in a constantly evolving energy market. Working in tandem, Sigma Catalog and Sigma CPQ will be added to a recently upgraded and comprehensive HubCX billing and customer-care platform – acting as digital enablers of the Simply Energy business and helping it continue to be an innovative, fast growing and successful energy retailer within the Australian market.”
For further information about HubCX or Hansen’s products Sigma Catalog and Sigma CPQ , please visit us at www.hansencx.com and www.sigma-systems.com .
About Simply Energy
Simply Energy is one of Australia’s fastest growing retail energy companies with more than 720,000 electricity and gas customer accounts. Simply Energy services Victoria, New South Wales, Queensland, Western Australia and South Australia providing great value energy deals for consumers and businesses.
ENGIE is a global energy provider spanning 70 countries and 5 continents. The ENGIE global network is an enterprise committed to long-term innovation and growth whilst adhering to a strict ethical code.
For more information on Simply Energy, visit simplyenergy.com.au
About Hansen Technologies
Hansen Technologies (ASX: HSN) is a leading global provider of software and services to the energy, water and communications industries. With its award-winning software portfolio, Hansen serves 550+ customers in over 80 countries, helping them to create, sell, and deliver new products and services, manage and analyse customer data, and control critical revenue management and customer support processes.
For more information, visit www.hansencx.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200128005711/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FlexTrade Expands Portfolio Risk and Analytics Capabilities Through Strategic Partnership with Portx13.7.2026 15:30:00 CEST | Press release
The collaboration expands FlexTrade’s front-office risk analytics offering, connecting portfolio construction, risk insight, and trading decisions in a unified buy-side workflow. FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, and Portx, an advanced portfolio construction and analytics provider, today announced the integration of Portx’sreal-time portfolio construction, optimization, and risk analytics capabilities into FlexTrade’s integrated buy-side order and execution management system (OEMS), FlexONE. The partnership comes as buy-side firms place greater emphasis on real-time risk management across increasingly complex portfolios, advanced hedging strategies, and supporting operating models. For hedge funds and institutional asset managers, particularly those running multi-strategy or multi-asset approaches, the ability to assess portfolio risk, review pro forma exposures, and act on those insights within the order and executio
Xsolla Connect Returns to Brighton13.7.2026 15:22:00 CEST | Press release
Connecting The UK Game Development Community For Networking And Insights During Develop:Brighton Xsolla, a global video game commerce company, today announced the launch of an exclusive networking event for the UK game development community, Xsolla Connect, taking place with Develop:Brighton 2026 on July 15, 2026. Designed to bring together independent and mid-tier developers, publishers, investors, and industry professionals, the event will offer a focused evening of meaningful connections and actionable insights at one of the UK’s most important annual games gatherings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713748542/en/ Graphic: Xsolla Develop:Brighton has long served as a cornerstone of the European video games industry, drawing developers, publishers, investors, and studio leaders from across the UK and beyond to share knowledge, explore opportunities, and forge lasting business relationships. Xsolla’s event
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)13.7.2026 14:32:00 CEST | Press release
Regulatory recognition in the United States and Europe supports the development of NB4168, a novel small molecule candidate for a rare pediatric disease with no approved treatments Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure than conventional NR while maintaining a differentiated pharmacokinetic and safety profile. In addition, the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation (OMPD) to NB4168 for the treatment of A-T, providing regulatory recognition in the European Union and further supporting the Company'
SLB OneSubsea Awarded EPC Contract for Eni’s Baleine Phase 3 Project Offshore Côte d'Ivoire13.7.2026 14:00:00 CEST | Press release
Integrated subsea production system and local capabilities enable accelerated deepwater development Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712734539/en/ SLB OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. Under the contract, SLB OneSubsea will deliver complete subsea production systems (SPS) for 13 wells, reinforcing its role as a core technology and execution partner on one of the most strategically significant offshore developments currently underway in the region. The EPC scope includes subsea trees, um
HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform13.7.2026 14:00:00 CEST | Press release
HistoSonics, today announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713505048/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image guided platform that is intended for the destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors. It uses the mechanical properties of focused ultrasound, called histotripsy, to liquefy and destroy unwanted tissue and tumors in a single procedure without the need for invasive procedures or radiation, and with potentially fewer side effects than traditional therapies. CE Mark approval follows an increasing number of regulatory clearances and was supported by a growing body of clinical ev
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
